Results 31 to 40 of about 27,020 (235)

Methods in pharmacoepidemiology

Therapies, 2019
Pharmacoepidemiology is the study of interactions between drugs and human populations, investigating, in real conditions of life, benefits, risks and use of drugs. Pharmacoepidemiology applies to drugs and their pharmacological evaluations, the different methods also used in epidemiology to assess in real conditions of life, benefits, risks and use of ...
Agnès, Sommet, Antoine, Pariente
openaire   +3 more sources

Identification of Risk-Related Prenatal Medication Exposure Profiles for Childhood Asthma Using the Bayesian Profile Regression: A Cohort Study Using the POMME Cohort. [PDF]

Pharmacoepidemiol Drug Saf
ABSTRACT Purpose To identify prenatal medication exposure profiles associated with childhood asthma. Methods This population‐based cohort study used data from the POMME (PrescriptiOn Médicaments Mères Enfants) cohort, including 18 851 children born in the Haute‐Garonne area (France) in 2010 and 2015, and followed until 2023.
Russo S, Bénévent J, Beau AB.
europepmc   +2 more sources

Pharmacoepidemiology of statins

Therapies, 2019
The evaluation of the real-life benefits and risks of statins in population is a major pharmacoepidemiological issue, given their widespread use for cardiovascular prevention. The purpose of this review was not to be exhaustive but to show the contributions of pharmacoepidemiology for various aspects of the evaluation of statins such as real-life drug ...
Julien, Bezin, Nicholas, Moore
openaire   +3 more sources

Pharmacokinetics and pharmacoepidemiology

, 1994
Pharmacokinetic methodology should be included in pharmacoepidemiology and postmarketing ...
J Zuidema, H G M Leufkens
core   +1 more source

Pharmacoepidemiology Research: delivering evidence about drug safety and effectiveness in mental health [PDF]

, 2019
There is a need for research that provides an evidence base for the pharmacotherapy of people with mental disorders. The abundance of digital data in recent years has facilitated pharmacoepidemiology in the form of observational comparative effectiveness
Farooq
core   +1 more source

Preregistration of high‐quality protocols in pharmacoepidemiology research

JCPP Advances
Pharmacoepidemiology studies are an important complement to Randomized Clinical trials, but such studies face several challenges, such as confounding and selective reporting.
Henrik Larsson, Zhang Chang, Kenneth K. C. Man   +2 more
doaj   +1 more source

Direct Oral Anticoagulants’ Consumption and Expenditure in the COVID-19 Pandemic in Russia and Clinical Practice Guidelines for Their Use

Pharmacoepidemiology, 2023
Background: The coronavirus pandemic has led to the creation of clinical guidelines by a large number of professional medical communities. However, the quality and methodology of development of Russian clinical guidelines has been little studied.
Elena A. Baybulatova, Mikhail S. Chenkurov, Elina A. Korovyakova, Sergey K. Zyryanov, Liliya Eugenevna Ziganshina   +4 more
doaj   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry [PDF]

Purpose: The first paper to specify the core content of pharmacoepidemiology as a profession was published by an ISPE (International Society for Pharmacoepidemiology) workgroup in 2012 (Jones JK et al. PDS 2012; 21[7]:677–689).
Cohet, Catherine, Pinheiro, Simone, Tilson, Hugh, Osborne, Vicki, Pont, Lisa, Chan, K. Arnold, Klungel, Olaf, Seeger, John, Edlavitch, Stanley, Bate, Andrew, Moeny, David, Winterstein, Almut G., PECP - Centre for Pharmacoepidemiology, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Brown, Joshua, Goodin, Amie, Layton, Deborah   +17 more
core   +2 more sources